A clinical case: gastric cancer after gastric bypass

   Introduction: Gastric cancer is one of the most common oncological diseases in the world, occupying the 5th place of morbidity and the 3rd place in the structure of mortality from oncological diseases. For a long time, issues affecting the risk of developing cancer after bariatric surgery remain relevant. Our observation is devoted to the diagnosis and treatment of a patient with gastric cancer after gastric bypass.

   Description of the clinical case: A 62‑year‑old patient was operated on 13. 07. 2016 – laparoscopic Roux gastric bypass for morbid obesity, 11.  09.  2019 – laparoscopic installation of the Cardioplant plate on a small stomach due to recurrent weight gain. Since 2020 the patient had the phenomena of anastomositis, dysphagia and gastroesophageal reflux. Courses of conservative therapy, sessions of balloon dilation of gastroenteroanastomosis and anastomosis resection failed to show a significant effect. The patient underwent comprehensive examinations at each treatment, including abdominal MSCT, cancer markers and studies of biopsy material of the gastric mucosa and gastroenteroanastomosis. As a result of histological studies, no signs of cancer were found. After applying to the Avicenna Medical Center in 2022 a molecular genetic analysis was carried out, in which the mRNA panel most corresponded to a malignant neoplasm. 20. 12. 2022 extirpation of the stomach stump with resection of the esophagus was performed. The cancer diagnosis was confirmed by histological and immunohistochemical studies: low‑grade adenocarcinoma of the stomach with a cricoid component with germination into the esophagus and small intestine, with spread beyond the muscle layer.

   Conclusion: This clinical case highlights the complexity of oncological verification in patients after bariatric surgery. Prolonged dysphagia, anastomositis and recurrent GERD in such patients determine the need for a more detailed examination, including the latest achievements of molecular genetic analysis.

1. Sung H., Ferlay J., Siegel R.L., et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2021;71(3):209–249. doi: 10.3322/caac.21660

2. The state of oncological care to the population of Russia in 2021. Eds.: А.D. Kaprin, V.V. Starinskiy, A.O. Shachzadova. Moscow: MNIOI im. P.A. Gertsena – filial FGBU “NMITS radiologii” Minzdrava Rossii, 2022.239 p. (in Russ.).

3. Malignant tumors in Russia in 2021 (morbidity and mortality). Eds.: А.D. Kaprin, V.V. Starinskiy, A.O. Shachzadova. Moscow: MNIOI im. P.A. Gertsena – filial FGBU “NMITS radiologii” Minzdrava Rossii, 2022.252 p. (In Russ.)

4. Adams T.D., Meeks H., Fraser A., et al. Long‑term all‑cause and cause‑specific mortality for four bariatric surgery procedures. Obesity (Silver Spring) 2023;31(2):574–585. doi: 10.1002/oby.23646

5. Aminian A., Wilson R., Al‑Kurd A., et al. Association of bariatric surgery with cancer risk and mortality in adults with obesity. JAMA 2022;327(24):2423–2433. doi: 10.1001/jama.2022.9009

6. Eisenberg D., Shikora S.A., Aarts E., et al. 2022 American Society of Metabolic and Bariatric Surgery (ASMBS) and International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO) indications for metabolic and bariatric surgery. Obes Surg 2023;33(1):3–14. doi: 10.1007/s11695-022-06332-1

7. Rustgi V.K., Li Y., Gupta K., et al. Bariatric surgery reduces cancer risk in adults with nonalcoholic fatty liver disease and severe obesity. Gastroenterology 2021;161(1):171–184. doi: 10.1053/j.gastro.2021.03.021

8. Tersmette A.C., Offerhaus G.J., Tersmette K.W., et al. Meta‑analysis of the risk of gastric stump cancer: detection of high risk patient subsets for stomach cancer after remote partial gastrectomy for benign conditions. Cancer Res 1990;50(20):6486–6489. PMID:2145061

9. Lundegårdh G., Adami H.O., Helmick C., Zack M. Risk of cancer following partial gastrectomy for benign ulcer disease. Br J Surg 1994;81(8):1164–1167. doi: 10.1002/bjs.1800810827

10. Scozzari G., Trapani R., Toppino M., Morino M. Esophagogastric cancer after bariatric surgery : systematic review of the literature. Surg Obes Relat Dis 2013;9(1):133–142. doi: 10.1016/j.soard.2012.10.002

11. Wu C.C., Lee W.J., Ser K.H., et al. Gastric cancer after mini‑gastric bypass surgery : A case report and literature review. Asian J Endosc Surg 2013;6(4):303–306. doi: 10.1111/ases.12052

12. Runkel M., Runkel N. Esophago‑gastric cancer after one anastomosis gastric bypass (OAGB). Chirurgia (Bucur) 2019;114(6):686–692. doi: 10.21614/chirurgia.114.6.686

13. Runkel M., Pauthner M., Runkel N. The first case report of a carcinoma of the gastric cardia (AEG II) after OAGB‑MGB. Obes Surg 2020;30(2):753–754. doi: 10.1007/s11695-019-04193-9

14. Musella M., Berardi G., Bocchetti A., et al. Esophagogastric neoplasms following bariatric surgery : an updated systematic review. Obes Surg 2019;29(8):2660–2669. doi: 10.1007/s11695-019-03951-z

15. Aggarwal S., Bhambri A., Singla V., et al. Adenocarcinoma of oesophagus involving gastro‑oesophageal junction following mini‑gastric bypass/one anastomosis gastric bypass. J Minim Access Surg 2020;16(2):175–178. doi: 10.4103/jmas.JMAS_320_18

16. Tornese S., Aiolfi A., Bonitta G., et al. Remnant gastric cancer after roux‑en‑y gastric bypass : narrative review of the literature. Obes Surg 2019;29(8):2609–2613. doi: 10.1007/s11695-019-03892-7

17. Anishchenko V.V., Arkhipova A.A., Titov S.E., et al. Analysis of miRNA and mRNA expression in the cellular material of the gastric mucosa obtained by esophagogastroduodenoscopy to detect dysplasia and gastric cancer. Surgical practice. 2021;(4):53–60 (in Russ.). doi: 10.38181/2223-2427-2021-4-53-60